Literature DB >> 11083860

The C terminus of mammalian phospholipase D is required for catalytic activity.

M Y Liu1, S Gutowski, P C Sternweis.   

Abstract

The activity of phospholipase D (PLD) is regulated by a variety of hormonal stimuli and provides a mechanistic pathway for response of cells to extracellular stimuli. The two identified mammalian PLD enzymes possess highly homologous C termini, which are required for catalytic activity. Mutational analysis of PLD1 and PLD2 reveals that modification of as little as the C-terminal threonine or the addition of a single alanine attenuates activity of the enzyme. Protein folding appears to be intact because mutant enzymes express to similar levels in Sf9 cells and addition of peptides representing the C-terminal amino acids, including the simple hexamer PMEVWT, restores partial activity to several of the mutants. Analysis of several mutants suggests a requirement for the hydrophobic reside at the -2-position but not an absolute requirement for the hydroxyl side chain of threonine at the C terminus. The inability of peptides amidated at their C termini to effect restoration of activity indicates the involvement of the C-terminal alpha carboxyl group in functional activity of these enzymes. The ability of peptides to restore activity to PLD enzymes mutated at the C terminus suggests a flexible interaction of this portion of the molecule with a catalytic core constructed on conserved HKD motifs. Participation of these C termini residues in either stabilization of the catalytic site or the enzymatic reaction itself remains to be determined. This requirement for the C terminus provides an excellent potential site for interaction with regulatory proteins that may either enhance or down-regulate the activity of these enzymes in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083860     DOI: 10.1074/jbc.M006404200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

3.  Endosomal localization of phospholipase D 1a and 1b is defined by the C-termini of the proteins, and is independent of activity.

Authors:  W E Hughes; P J Parker
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

4.  Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

Authors:  Fu-Long Li; Zhengming Wu; Yong-Qi Gao; Forrest Z Bowling; J Matthew Franklin; Chongze Hu; Raymond T Suhandynata; Michael A Frohman; Michael V Airola; Huilin Zhou; Kun-Liang Guan
Journal:  EMBO J       Date:  2022-07-17       Impact factor: 14.012

Review 5.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

6.  Human PLD structures enable drug design and characterization of isoenzyme selectivity.

Authors:  Claire M Metrick; Emily A Peterson; Joseph C Santoro; Istvan J Enyedy; Paramasivam Murugan; TeYu Chen; Klaus Michelsen; Michael Cullivan; Kerri A Spilker; P Rajesh Kumar; Tricia L May-Dracka; Jayanth V Chodaparambil
Journal:  Nat Chem Biol       Date:  2020-02-10       Impact factor: 15.040

7.  Crystal structure of plant PLDα1 reveals catalytic and regulatory mechanisms of eukaryotic phospholipase D.

Authors:  Jianxu Li; Fang Yu; Hui Guo; Renxue Xiong; Wenjing Zhang; Fangyuan He; Minhua Zhang; Peng Zhang
Journal:  Cell Res       Date:  2019-10-16       Impact factor: 46.297

8.  Small methyltransferase RlmH assembles a composite active site to methylate a ribosomal pseudouridine.

Authors:  Cha San Koh; Rohini Madireddy; Timothy J Beane; Phillip D Zamore; Andrei A Korostelev
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

9.  Structural insights into PA3488-mediated inactivation of Pseudomonas aeruginosa PldA.

Authors:  Xiaoyun Yang; Zongqiang Li; Liang Zhao; Zhun She; Zengqiang Gao; Sen-Fang Sui; Yuhui Dong; Yanhua Li
Journal:  Nat Commun       Date:  2022-10-10       Impact factor: 17.694

Review 10.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.